This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Coronary atherosclerosis
  • /
  • Cost-effectiveness of Evolocumab Therapy for Reduc...
Journal

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.

Read time: 1 mins
Published:23rd Aug 2017
Author: Fonarow GC, Keech AC, Pedersen TR, Giugliano RP, Sever PS, Lindgren P et al.
Source: JAMA Cardiology
Availability: Free full text
Ref.:JAMA Cardiol. 2017.
DOI:10.1001/jamacardio.2017.2762
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest